These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 196820

  • 21. Essentials in the management of myasthenia gravis.
    Galdi AP.
    Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
    [Abstract] [Full Text] [Related]

  • 22. [Current therapy of myasthenia].
    Zumstein V, Regli F.
    Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
    [No Abstract] [Full Text] [Related]

  • 23. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
    Eppel M, Streib EW.
    Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214
    [No Abstract] [Full Text] [Related]

  • 24. Management of myasthenia gravis.
    Schwendimann RN, Burton E, Minagar A.
    Am J Ther; 2005 Apr; 12(3):262-8. PubMed ID: 15891271
    [Abstract] [Full Text] [Related]

  • 25. Corticotropin therapy and thymectomy in management of severe, generalized myasthenia gravis.
    Namba T, Shapiro MS, Brunner NG, Grob D.
    Trans Am Neurol Assoc; 1970 Apr; 95():295-7. PubMed ID: 4328100
    [No Abstract] [Full Text] [Related]

  • 26. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
    Ricken D.
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
    [No Abstract] [Full Text] [Related]

  • 27. The treatment of patients with myasthenia gravis.
    Sanders DB, Scoppetta C.
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [Abstract] [Full Text] [Related]

  • 28. Graded response to thymectomy in children with myasthenia gravis.
    Tracy MM, McRae W, Millichap JG.
    J Child Neurol; 2009 Apr; 24(4):454-9. PubMed ID: 19339286
    [Abstract] [Full Text] [Related]

  • 29. Current treatment of myasthenia gravis.
    Osterman PO.
    Prog Brain Res; 1990 Apr; 84():151-61. PubMed ID: 2267293
    [No Abstract] [Full Text] [Related]

  • 30. [Immunosuppressive therapy of myasthenias].
    Mertens HG, Hertel G.
    Med Welt; 1973 Jun 08; 24(23):955-63. PubMed ID: 4355431
    [No Abstract] [Full Text] [Related]

  • 31. Overview of myasthenia gravis.
    Arora Y, Li Y.
    Hosp Pract (1995); 2013 Jun 08; 41(4):40-50. PubMed ID: 24145588
    [Abstract] [Full Text] [Related]

  • 32. Ocular myasthenia gravis.
    Gilbert ME, Savino PJ.
    Int Ophthalmol Clin; 2007 Jun 08; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract] [Full Text] [Related]

  • 33. [Myasthenia gravis. Treatment].
    Somnier FE.
    Ugeskr Laeger; 1984 Jan 30; 146(5):345-8. PubMed ID: 6719608
    [No Abstract] [Full Text] [Related]

  • 34. Management of myasthenia gravis.
    Saperstein DS, Barohn RJ.
    Semin Neurol; 2004 Mar 30; 24(1):41-8. PubMed ID: 15229791
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients.
    Dau PC.
    Ann N Y Acad Sci; 1981 Mar 30; 377():700-8. PubMed ID: 6951494
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.